Fall 2024 Prime Therapeutics Report - Prime Therapeutics
publications
Fall 2024 Prime Therapeutics Report
October 21, 2024
Debuting a new name and design, the 41st edition of our managed care report still offers the same in-depth industry articles on trending specialty topics.
Get the latest updates on CAR T therapy, non-small cell lung cancer, oncology accelerated approval, acute myeloid leukemia, and more!
Explore the report
Get the latest updates on CAR T therapy, non-small cell lung cancer, oncology accelerated approval, acute myeloid leukemia, and more!
Explore the report